Key Metrics
CiteScore 

21.7
Scite Index 

0.86 5-Year SI

SNIP 

6.5
Recommended pre-submission checks
Powered by 

The Lancet Child and Adolescent Health Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | ELSEVIER SCI LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2017 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in The Lancet Child and Adolescent Health ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in The Lancet Child and Adolescent Health
Efficacy and safety of risdiplam in patients with type 1 spinal muscular atrophy: a 3-year open-label extension of the two-part, phase 2 FIREFISH trial.
- 1 Sep 2026
- The Lancet. Child & adolescent health
Orphanhood and caregiver loss after Venezuela's earthquake doublet: an overlooked child health crisis.
- 1 Sep 2026
- The Lancet. Child & adolescent health
A national programme of bivalent prefusion F vaccination in pregnancy and protection against respiratory syncytial virus hospitalisation in infants until age 6 months in the UK: a multicentre, prospective, test-negative, case-control study.
- 1 Sep 2026
- The Lancet. Child & adolescent health
Associations between childhood somatic conditions and psychiatric diagnoses in autistic young adults: a retrospective, population-based cohort study in Sweden.
- 1 Sep 2026
- The Lancet. Child & adolescent health
A decade of disease-modifying therapies for spinal muscular atrophy.
- 1 Sep 2026
- The Lancet. Child & adolescent health
From PCOS to PMOS: inclusion of the adolescent voice in setting clinical and research priorities.
- 1 Sep 2026
- The Lancet. Child & adolescent health
Efficacy and safety of risdiplam in patients with type 1 spinal muscular atrophy: a 3-year open-label extension of the two-part, phase 2 FIREFISH trial.
- 1 Sep 2026
- The Lancet. Child & adolescent health
Orphanhood and caregiver loss after Venezuela's earthquake doublet: an overlooked child health crisis.
- 1 Sep 2026
- The Lancet. Child & adolescent health
A national programme of bivalent prefusion F vaccination in pregnancy and protection against respiratory syncytial virus hospitalisation in infants until age 6 months in the UK: a multicentre, prospective, test-negative, case-control study.
- 1 Sep 2026
- The Lancet. Child & adolescent health
Associations between childhood somatic conditions and psychiatric diagnoses in autistic young adults: a retrospective, population-based cohort study in Sweden.
- 1 Sep 2026
- The Lancet. Child & adolescent health
A decade of disease-modifying therapies for spinal muscular atrophy.
- 1 Sep 2026
- The Lancet. Child & adolescent health
From PCOS to PMOS: inclusion of the adolescent voice in setting clinical and research priorities.
- 1 Sep 2026
- The Lancet. Child & adolescent health